Raltitrexed
Pleural Neoplasm
City of Hope Medical CenterSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Pleural Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin City of Hope Medical Center | Phase 2 | CCC |
Idarubicine City of Hope Medical Center | Phase 2 | CCC |
MITOMYCIN C City of Hope Medical Center | Phase 2 | CCC |
Ethiodized Oil City of Hope Medical Center | Phase 2 | CCC |
Same molecule, other indications
Raltitrexed is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →